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Dimitrios RovithisAbstract
Economic evaluation in modern health care systems is seen as a transparent scientific framework that can be used
to advance progress towards improvements in population health at the best possible value. Despite the perceived
superiority that trial-based studies have in terms of internal validity, economic evaluations often employ
observational data. In this review, the interface between econometrics and economic evaluation is explored, with
emphasis placed on highlighting methodological issues relating to the evaluation of cost-effectiveness within a
bivariate framework. Studies that satisfied the eligibility criteria exemplified the use of matching, regression analysis,
propensity scores, instrumental variables, as well as difference-in-differences approaches. All studies were reviewed
and critically appraised using a structured template. The findings suggest that although state-of-the-art econometric
methods have the potential to provide evidence on the causal effects of clinical and policy interventions, their
application in economic evaluation is subject to a number of limitations. These range from no credible assessment
of key assumptions and scarce evidence regarding the relative performance of different methods, to lack of
reporting of important study elements, such as a summary outcome measure and its associated sampling
uncertainty. Further research is required to better understand the ways in which observational data should be
analysed in the context of the economic evaluation framework.
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Trial-based studies are regarded as the gold standard in
evaluative research since the assignment of individuals into
treatment is typically random, independent of covariates
and potential outcomes, ensuring in this way the highest
possible internal validity [1]. Nevertheless, pragmatic
reasons require economic evaluations to also rely on
observational economic and clinical data [2]. Studies
using observational data are prone to selection bias,
with the treatment effect potentially being confounded
with individual, provider or other characteristics [3].
Selection bias constitutes a major threat to the internal val-
idity of a study and unless its presence can be minimised
the estimated treatment effects do not necessarily imply a
cause and effect relationship [4].Correspondence: publication-enquiry@rovithis.info
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in any medium, provided the original work is pOver the years, a number of econometric methods that
deal with selection bias have been developed, depending on
whether the source of bias is observed or not [5]. Such ana-
lytical approaches operate in the context of the potential
outcomes framework and include matching, regression ana-
lysis, propensity scores, instrumental variables, regression
discontinuity designs, difference-in-differences approaches
and control functions [6]. Their key task is the construction
of the counterfactual outcome, when the evaluation
problem is the measurement of a treatment effect in
the presence of non-random selection into treatment.
Non-experimental evaluation methods have the potential
to estimate a single average effect, or look into the hetero-
geneity of individuals’ responses to the intervention of
interest, depending on the nature of the research
question, the richness and type of the available data,
as well as the postulated model for outcome and selection
processes [7].pen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Rovithis Health Economics Review 2013, 3:21 Page 2 of 7
http://www.healtheconomicsreview.com/content/3/1/21Detailed exposition of these methods and examples of
their use in a range of applications has been reviewed else-
where [8,9]. The aim of this study is to identify which
methods are currently used in economic evaluation stud-
ies employing observational data and discuss the scope
and scientific quality of the current evidence-base, in
order to identify gaps in our knowledge and to consider
the future research agenda.
Review
Eligibility criteria and identification strategy
A review of the international English language literature
was undertaken. The eligibility criteria for inclusion
required studies to be full economic evaluations as
defined by Drummond et al. [10] and use observational
microdata referring to the same population for both the
cost and effectiveness outcome. The review placed par-
ticular emphasis on identifying methods than including
all applications. As such, only studies that demonstrated
some modification in the methodology addressing selec-
tion bias were included. In addition, studies should use
an econometric method to adjust at least one of the cost,
effectiveness and cost-effectiveness outcomes.
The studies reviewed were identified using a four-stage
process. First, three generic electronic bibliographic data-
bases, namely MEDLINE, EMBASE, and Econlit were
searched through the OvidSP interface in order to generate
as many papers of potential methodological interest as pos-
sible for the years 1990-2010. Second, additional searches
for the same time period were carried out in three
specialised databases: NHS EED, HEED and CEA Registry.
The search strategy, which was adapted for each database,
combined and interacted the terms “cost*”, “effect*”, “bene-
fit*”, “cost-effective*” and “cost-benefit*”, with “matching”,
“stratification”, “regression*”, “propensity score*”, “instru-
mental variable*”, “difference in difference*”, “control func-
tion” and “discontinuity”. Third, the database searching was
supplemented by communicating with other experts.
The expert communication involved sending a brief
outline of the review objectives, together with a list
of key publications to individuals working in similar
research areas. Colleagues were requested to suggest
further published, unpublished or work-in-progress
research for inclusion in the review. Experts were
identified through the literature, known contacts and
posting on relevant online discussion lists. Fifth, an
examination of the references and the citations of all
eligible studies was undertaken, with a view to iden-
tify further papers that were not already captured
during the previous stages.
Review process
In methodologically allied sciences such as epidemiology,
a checklist of items that should be included in studiesreporting observational research has been established [11].
In the absence of a similar methodological inquiry for eco-
nomic evaluation, all papers here were reviewed using a
custom-made structured template, (Additional file 1) the
development of which was informed by a conceptual review
of non-experimental methods that can be used for the
evaluation of treatment effects. The template comprised of
three parts aiming to extract relevant factual information
from each study and critically appraise important aspects of
their methodology. More specifically, the first part recorded
general characteristics such as bibliographic information,
the type of economic evaluation undertaken, whether a
summary cost-effectiveness outcome measure was used, as
well as the interventions evaluated. In the second part, the
template focused on extracting the method(s) adjusting for
selection bias, the estimation techniques employed and
whether adjustment was undertaken for costs, effectiveness
or cost-effectiveness. Any comparisons with other methods
or studies, the types of uncertainty evaluated and the au-
thors’ conclusions with respect to the ability of methods to
adjust for selection bias were also extracted. Finally, the
third part recorded information relating to the justification
of choice of method and the specification(s) used, as well as
whether any relevant tests or graphical analyses were car-
ried out. A reviewer’s assessment concerning potential
weakness of the study was also included. This was based on
the extracted information as these were provided by the au-
thors and placed particular emphasis on assessing the
plausibility of the assumptions postulated by the analytical
method employed.
Methods such as regression analysis, matching, ‘sharp’
regression discontinuity designs, as well solutions relying
on the propensity score require the selection on observ-
ables assumption and common support for baseline
covariates between the treatment groups [7]. The idea
here is that in groups with sufficient overlapping base-
line characteristics, treatment assignment of individuals
is said to be “as good as random”, with potential out-
comes being independent of treatment status [12]. In
cases of imbalance, once the analyst conditions on a set
of observable confounders, it is assumed that there are
no differences in the distributions of unobserved con-
founders which are correlated with those that are
observed [13]. Regression analysis and difference-in-dif-
ferences quasi-experimental designs can obtain the
treatment effect under weaker conditions as long as
longitudinal data are used. In such cases, what is typ-
ically assumed is that unobserved confounders corre-
lated with treatment assignment and the outcomes are
time-invariant [14]. For example, the conventional
difference-in-differences approach assumes that the
composition of individuals in the treatment and con-
trol groups follows a parallel path over time [15]. On
the other hand, methods making use of exclusion
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‘fuzzy’ regression discontinuity designs) can explicitly
address selection on unobservables, arising from specifica-
tion errors, endogeneity and unobserved heterogeneity [6].
The principal assumptions under which these methods
operate require that the exclusion restriction is strongly
correlated with treatment, it only influences outcomes
through treatment and it is independent of unobserved
confounders [16]. Finally, a further assumption for unbiased
treatment effect estimates in parametric implementations
of these methods is that the model reflects the true
relationship between the outcome of interest and the
covariates used for the adjustment [17].
Results
A schematic diagram of the overall identification process
is presented in Figure 1. The original search strategy
yielded a total of 6,647 unique studies. Additional inde-
pendent search strategies in the three specialised databases
returned 3,640 studies in NHS EED, 2,708 in HEED and 60
in the CEA Registry. Requests for studies from other
experts yielded a further 18 studies. All studies underwent
a screening process to ensure that they met the eligibility
criteria of the review. It should be noted that when it was
apparent from the title or abstract that a study failed on
any of these criteria, it was discarded. When it was unclear
or if any doubt remained, the full paper was examined. Fol-
lowing the review of titles and abstracts, full text copies
were obtained for 383 potentially relevant studies. After
assessment, 342 were excluded from the review becauseMEDLINE (3,767 ) EMBASE (5,394 ) 
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Figure 1 Schematic diagram of the identification strategy and reviewthey did not meet the eligibility criteria. Cross-reference
checks of the selected studies yielded another 2 relevant
studies that satisfied the eligibility criteria. The final sample
of the studies fully reviewed using an equivalent number of
structured templates comprised of 43 studies.
Table 1 provides a summary of the results of the review
(Additional file 2). As it can be seen, around a third of the
economic evaluations included in the review did not report
a summary outcome measure, whereas half of the studies
failed to report in a precise and transparent manner in-
formation relating to sampling uncertainty for cost-
effectiveness. A relatively small percentage of studies
evaluated multiple interventions but the majority did not
consider explicitly the issue of how these should be han-
dled in the analysis and relied on pairwise comparisons
of interventions. In terms of analytical methods cur-
rently employed to adjust for selection bias, the re-
view identified five broad categories, which were
mostly applied in sample sizes of 5000 individuals or
less. These include different methods matching on in-
dividual covariates, some form of regression analysis
using cross-sectional or longitudinal data; propensity
score analysis either through matching, or regression
modelling using the propensity score as a covariate;
difference-in-differences approaches; and instrumental var-
iables analysis. Solutions based on the propensity score
dominated the sample of the reviewed studies.
The majority of studies failed to adequately assess the
assumptions postulated by each method. For example,
studies relying on matching, regression and propensityECONLIT (890 ) 
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Table 1 Main characteristics of the reviewed studies
Type of study
Cost-effectiveness analysis (70%) Cost-Utility Analysis (30%)
Type of journal
Statistics/Econometrics (7%) Health Economics (19%) Health Services (30%) Medical (39%) Working Paper (5%)
Year of publication
1990 – 2000 (14%) 2001 – 2010 (86%)
Type of intervention
Surgical (37%) Medical (33%) Rehabilitation (5%) Public Health Policy (14%)
Diagnostic (2%) Preventative (9%)
Number of interventions
Two (74%) Three or more (26%)
Sample size
100 – 1000 (33%) 1001 – 5000 (29%) 5001+ (33%) Not reported (5%)
Summary outcome
None (35%) Incremental Cost-Effectiveness
Ratio (51%)
Net Benefit (14%)
Evaluation of uncertainty on summary outcome
Yes (43%) No (6%) Partial/Unclear (51%)
Method addressing selection bias
Regression Analysis (28%) Covariate Matching (7%) Propensity Scores (49%) Instrumental Variables (7%) Difference-in-Differences (9%)
Assessment of methods’ assumptions
Detailed (9%) Partial or None (91%)
Comparison of analytical methods
Yes (23%) No (77%)
Effort to contrast findings with other studies
Yes (47%) No (53%)
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ables assumption by providing a simple description for
the confounders adjusting. Overlap between treatment
groups was explored mostly through standard tests that
assess heterogeneity, although in studies where regression
analysis was employed, balance between groups was some-
times investigated using models that assessed whether sig-
nificant interactions were present between treatment and
covariates. Studies employing some form of matching
assessed covariate balance post-matching by comparing
means in the resulting groups. Economic evaluations relying
on difference-in-differences approaches typically assessed
the parallel path assumption by comparing pre-existing
time trends, whereas analyses exploiting the use of instru-
ments to achieve quasi-randomisation mostly assessed the
relevance of the instrument but not its validity. Studies
using parametric models rarely assessed functional form
assumptions through formal statistical tests and no studies
employed any graphical analysis for visual inspection.
Finally, almost half of the reviewed studies attempted to
contrast their findings with those obtained from otherstudies, while a small percentage directly compared
the results that different methods produced.
Discussion
Economic evaluations often employ observational data.
Econometric methods can only adjust for selection bias
by relying on assumptions that should approximately be
met. Although these assumptions are mostly untestable,
their credibility in a particular setting can be assessed
and analysts engaging in applied economic evaluation
should always undertake extensive checking procedures
to confirm the robustness of their results. In fact, this
process may often require more effort than the estimation
of the treatment effect itself.
The review revealed that this is typically not the case.
The published economic evaluation literature currently
routinely applies econometric methodology without care-
fully considering whether the key assumptions under
which these methods operate hold. For example, reviewed
studies making use of methods that assume selection on
observables rarely used findings from prior research or
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interventions and outcomes. These studies also did not
report the conduct of observational ‘placebo’ tests [18], or
sensitivity analyses such as Rosenbaum’s bounds simulating
the likely presence and impact of unobserved confounders
[19]. Similarly, alternative specifications considering varying
sets of covariates or different functional forms in regression
models were only reported in the few studies published in
statistical and health economics journals, aiming to offer
a more methodological treatment of the evaluation. In
addition, in studies where individuals between treatment
groups are not comparable, parametric methods may
extrapolate beyond the support provided by the available
data [20]. The literature currently is dominated by studies
that do not adequately assess the common support
assumption. For instance, although no statistically signifi-
cant interactions between treatment and covariates may be
identified, imbalances may still remain [21]. Graphical ana-
lysis such as histograms or smoothed density plots can be
very effective in detecting areas of insufficient overlap and
can complement statistical tests.
Matching methods can act as a data pre-processing
stage before inference [17]. This approach allows the
analyst to consider problems of imbalance in individual
covariates and assess overlap between treatment groups in
a direct and explicit manner, both before and after adjust-
ment [13]. Authors of economic evaluations employing
some form of matching often failed to report details
regarding the type of matching performed and generally
did not consider different methods in their analyses. Alter-
native matching procedures, as well as different values of
key estimator parameters can have important implications
with regards to the bias-efficiency trade-off inherent in all
these methods and may also result in varying interpreta-
tions of the treatment effect [12]. Studies using matching
reported balance tests relying on mean differences, as well
as standardised differences. The latter will typically be pre-
ferred as they are not affected by sample size and therefore
can be used for comparisons between treatment groups
that contain different numbers of individuals [22]. Never-
theless, solutions relying on the propensity score require
post-match balance in the entire distribution of individual
covariates. As such, higher moments including variance,
skewness, and kurtosis, as well as cross-moments such as
the covariance, should ideally be examined [17]. This was
something that nearly all relevant studies included in the
review failed to report. For continuous covariates, graphical
analyses using quantile–quantile plots and side-by-side
boxplots, or Kolmogorov–Smirnoff non-parametric tests of
the equality of distributions can consider the full covariate
distribution and thus be more informative [20,23].
For studies relying on exclusion restrictions to account
for unobservables, it is crucial for the analyst to deter-
mine whether these are relevant and valid in a particularsetting [7]. In a purely statistical context, random assign-
ment in a trial meets all the required assumptions and
as such it is an exclusion restriction by definition. In
contrast, in observational studies, particularly in socially
behavioural settings, choice of convincing exclusion
restrictions will often be less straightforward and will
have to be justified on qualitative rather than empirical
grounds [24]. For economic decision-making, strong
exclusion restrictions will require the analyst to go through
the challenging process of crafting plausible natural experi-
ments, which exploit extensive demand and supply side in-
formation to construct variables that can induce strong
external variation in the treatment assignment of individ-
uals [25]. In their quest for finding an instrument that satis-
fies the assumed properties laid out above, studies included
in this review often employed a well-known tactic in eco-
nomics, which involves exploiting the use of geographical
variables. Nevertheless, the externality of an instrument
does not necessarily also assures exogeneity; that is, it does
not automatically fulfil the orthogonality condition required
for consistent estimation in the instrumental variable con-
text [26]. Indeed, the economic evaluation by Polsky and
Basu [27] should act as a reminder that the performance of
an instrument will not always be guaranteed.
At this point, it is important to stress that the applica-
tion of different methods will ultimately depend on the
availability of data. Econometric methods are all data
driven, being applicable only in situations where relevant
microdata can be accessed to support them and as long
as the analysis takes advantage of their availability.
Administrative data can potentially provide the analyst
with the ability to link information from multiple databases
creating datasets containing more complete data on
individuals over time, additional background and demo-
graphic variables, as well as data on participants and
non-participants [28]. In addition, routinely collected
information is increasingly shifting from data related
to processes of care and patient outcomes such as
mortality and morbidity, to data related to more complex
measures of health status [29]. These considerations can
expand the range of non-experimental methods that
can be used to measure treatment effects.
A key aspect of the review appraisal was to consider
whether a comparison of cost-effectiveness estimates
with existing evidence was attempted, or whether studies
explored the sensitivity of their results to alternative
methods. The motivation for the former rests on the fact
that estimates from other relevant studies, when available,
can potentially offer a prior indication regarding the
direction of the treatment effect. This is particularly
true for evidence generated from randomised trials,
which in principle can constitute an important benchmark
for learning about non-experimental methods [30,31].
Unfortunately, when comparisons of this kind were
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qualitative in nature, relating to overall conclusions or
comparing only certain outcomes such as costs, survival or
hospitalisations. Some economic evaluations restricted the
scope of their comparisons to those across methods. Such
comparisons can also act as sensitivity analysis when the
availability of data allows the use of alternative analytical
approaches, which rely on different assumptions and have
the potential to exhibit variable performance in differ-
ent settings. For example, in the econometrics literature,
choice among estimators that rely on the selection on
observables assumption is normally warranted on small
sample arguments [6]. Currently, the embryonic nature of
such evidence in the studies reviewed does not allow any
firm conclusions to be drawn regarding the relative
ability of different methods or their combinations to
reduce selection bias in the context of cost-effectiveness.
However, what is clear is that choice of method may not
only influence estimates, but can also fundamentally alter
conclusions [26].
In addition, no economic evaluations identified by
this review employed any ‘doubly robust’ approaches,
which typically involve the use of regression analysis
in combination with some form of weighting. For example,
Robins and colleagues [32] proposed the use of the inverse
propensity score to weigh a regression model, offering in
this way additional protection against misspecification.
More recently, doubly robust estimation has been extended
to instrumental variable analysis [33,34]. Another strand of
this type of research that gets increasing attention in the
econometrics literature is the use of regression analysis
after matching. This is a ‘bias-correction’ solution that has
been shown to correct for remaining finite sample bias,
while potentially also making violations of functional form
assumptions less consequential [35,36]. Given the greater
potential for misspecification that arises from the consider-
ation of economic and clinical endpoints in the analysis,
the development of such approaches for evaluating
cost-effectiveness and their comparison with standalone
solutions is highly desirable.
In economic evaluation for decision-making, three
additional issues merit attention [10]. First, incremental
costs and effectiveness should be combined in a summary
outcome measure. Second, the analyst must quantify and
evaluate the sampling variability in this cost-effectiveness
estimate. Third, the analysis must ideally take into consid-
eration all relevant comparators. The review revealed that
a number of studies did not combine incremental costs
and effectiveness. Summary outcome measures are used
by decision-makers to help make policy recommendations
on the allocation of resources for competing health care
interventions [37]. In the absence of a summary outcome
measure, evaluating sampling uncertainty for the purpose
of cost-effectiveness will not be possible. In addition, thereseems to be a lack of transparency in the reporting of such
information. For example, reviewed studies failed to
report which bootstrap method was used to construct
the reported confidence intervals, or did not provide
any justification for the number of replications employed.
The use of multiple comparators in an economic evaluation
also raises the question of how these should be handled in
the econometric analysis. Some studies identified by the
review have shown that in regression analysis the use
of multinomial choice models can act as an alternative to
pairwise comparisons of interventions. Although these
approaches have also been exemplified in the economet-
rics literature for propensity score matching [38] and
doubly robust methods [39], no such extensions in the
context of cost-effectiveness were identified.
This review is subject to certain caveats, which must be
acknowledged. First, the conclusions of this review do not
apply to all economic evaluations that use observational
data. Decision analytical modelling-based studies, as well as
studies employing hypothetical data or summary evidence
for costs and effectiveness were considered beyond the
scope of this review and were excluded. In addition,
methods dealing with issues relevant to missing and cen-
sored data were also not included. Second, the review
should not be considered an exhaustive investigation of the
applied economic evaluation literature employing observa-
tional microdata. Nevertheless, a four-stage identification
process ensured that as many studies as possible exemplify-
ing modifications of analytical approaches were captured.
Finally, it should also be acknowledged that only one re-
viewer carried out the review of studies. As such, although
a structured template was used in an attempt to streamline
the review process and render the appraisal of studies more
rigorous, the categorisation of the collected information
and the interpretation of the findings presented here may
be subject to a certain degree of subjectivity.
Conclusions
Estimation of treatment effects in economic evaluation
involves considerable challenges when observational data
are used. The aim of this structured review was to iden-
tify econometric methods that can be used to evaluate
the cost-effectiveness of health care interventions and
critically appraise their application in economic evalua-
tions employing such data. Available methods adjust
for selection bias using an array of mostly untestable
assumptions, with a cost-effectiveness evaluation requiring
consideration of a broader range of issues compared to
other observational studies. Current limitations include
inadequate assessment of the credibility of fundamental
assumptions; absence of good quality evidence regarding
the sensitivity of results to different analytical approaches
or variations in crucial estimator parameters; failure
to combine incremental costs and effectiveness in a
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uncertainty for the purpose of evaluating cost-effectiveness;
and unclear handling of multiple interventions. Future
research should exemplify robust analyses that explicitly
acknowledge these issues and address them in a convincing
manner.
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